nomifensine has been researched along with Dysarthosis in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All patients had dystonia as their major clinical manifestation but also had dysarthria and at the presentation of the disease had choreoathetoid movements in at least one limb." | 1.29 | Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. ( Andersson, Y; Aquilonius, SM; Hartvig, P; Hörnfeldt, K; Långström, B; Tedroff, J; Thuomas, KA; Westermark, K, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Westermark, K | 1 |
| Tedroff, J | 1 |
| Thuomas, KA | 1 |
| Hartvig, P | 1 |
| Långström, B | 1 |
| Andersson, Y | 1 |
| Hörnfeldt, K | 1 |
| Aquilonius, SM | 1 |
1 other study available for nomifensine and Dysarthosis
| Article | Year |
|---|---|
Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
Topics: Adult; Anti-Bacterial Agents; Binding Sites; Brain; Caudate Nucleus; Ceruloplasmin; Copper; Corpus S | 1995 |